Literature DB >> 14661058

Plakoglobin is a new target gene of histone deacetylase in human fibrosarcoma HT1080 cells.

Joong Sup Shim1, Dong Hoon Kim, Ho Jeong Kwon.   

Abstract

Histone deacetylase (HDAC) plays a key role in gene expression, by suppressing the transcription of a number of target genes. Identification of such genes is important for deciphering the functional role of HDAC. Here, using cancer gene-focused DNA microarray analysis, we identified plakoglobin as a new target gene of HDAC. Functional inhibition of HDAC by its specific inhibitors induced the expression of plakoglobin by eight-fold in human fibrosarcoma HT1080 cells. However, the expression of beta-catenin, which is closely related to plakoglobin, was not altered, implying the specific function of HDAC in plakoglobin expression. Using antiacetyl-H4 antibody, chromatin immunoprecipitation analysis revealed that the distal region (-945 approximately -646) of the promoter of plakoglobin is responsible for the HDAC-mediated repression of the gene. Moreover, the induced expression of plakoglobin by the inhibition of HDAC activated the Tcf/Lef-dependent luciferase reporter gene, a well-known downstream effector of the Wnt signaling pathway. Furthermore, transient transfection of plakoglobin also activated Tcf/Lef reporter gene expression. Taken together, our results demonstrate that plakoglobin is a new target gene governed by HDAC, and that it acts as an oncogene in HT1080 cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14661058     DOI: 10.1038/sj.onc.1207289

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  5 in total

1.  Plakoglobin rescues adhesive defects induced by ectodomain truncation of the desmosomal cadherin desmoglein 1: implications for exfoliative toxin-mediated skin blistering.

Authors:  Cory L Simpson; Shin-ichiro Kojima; Victoria Cooper-Whitehair; Spiro Getsios; Kathleen J Green
Journal:  Am J Pathol       Date:  2010-11-12       Impact factor: 4.307

2.  The thyroid cancer PAX8-PPARG fusion protein activates Wnt/TCF-responsive cells that have a transformed phenotype.

Authors:  Dang Vu-Phan; Vladimir Grachtchouk; Jingcheng Yu; Lesley A Colby; Max S Wicha; Ronald J Koenig
Journal:  Endocr Relat Cancer       Date:  2013-09-11       Impact factor: 5.678

Review 3.  Desmosomes: regulators of cellular signaling and adhesion in epidermal health and disease.

Authors:  Jodi L Johnson; Nicole A Najor; Kathleen J Green
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

Review 4.  Therapeutic applications of histone deacetylase inhibitors in sarcoma.

Authors:  Fan Tang; Edwin Choy; Chongqi Tu; Francis Hornicek; Zhenfeng Duan
Journal:  Cancer Treat Rev       Date:  2017-07-06       Impact factor: 12.111

5.  N-glycosylation gene DPAGT1 is a target of the Wnt/beta-catenin signaling pathway.

Authors:  Pritam K Sengupta; Meghan P Bouchie; Maria A Kukuruzinska
Journal:  J Biol Chem       Date:  2010-08-06       Impact factor: 5.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.